In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
2don MSNOpinion
As the 119th Congress convenes, policymakers have a historic opportunity to lower prescription drug prices for Americans. As ...
At least one Woodward pharmacist is celebrating an action by Oklahoma Attorney General Gentner Drummond that could turn the tide for area pharmacists, some who are struggling stay in business ...
Oklahoma's attorney general has accused CVS's Caremark pharmacy benefit manager unit of under-reimbursing pharmacies for ...
Sen. James Lankford has been trying to pass legislation in response to an industry he believes will leave small towns without ...
The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.
As Lina Khan, chair of the Federal Trade Commission, ends her tenure this week the FTC posted a second report in six months ...
HB1150 would ban the around 35 PBM-owned pharmacies in the state and prevent over 100 out-of-state PBM-owned pharmacies from ...
FTC Chair Lina Khan has the big three pharmacy benefit managers in sight—UnitedHealth's OptumRx, Cigna's Express Scripts and CVS Caremark Rx. © 2024 Fortune Media ...
A new report by the Federal Trade Commission says pharmacy benefit management companies are driving up your out-of-pocket costs for prescription drugs. A new report by the Federal Trade Commission ...
The Federal Trade Commission (“FTC”) released its second interim report on Jan. 14, 2025, accusing pharmacy benefit managers (PBMs) of marking up the prices of specialty generic drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback